Back to eLearning

eLearning

3.08 | PRESCRIBER AND DISPENSER TRAINING - High-risk clinical scenarios

 

MODULE NAME:High-risk clinical scenarios
MODULE CODE:L3.8 -12
COURSE NAME:PRESCRIBER AND DISPENSER TRAINING
LEARNING LEVEL:Level 3 - AOD Treatment Specific Practice
TARGET AUDIENCE:Health practitioners who are able to prescribe or dispense monitored medicines and access QScript.
MODULE TYPE:Elective
MODULE AIM:

Completion of this module will enable prescribers and pharmacists to understand the clinical application of QScript’s high-risk clinical scenarios and the related notification function. This module will discuss each high-risk clinical scenario where a patient may be at risk of serious harms associated with the use of monitored medicines. 

Under the Medicines and Poisons Act 20191 relevant practitioners (medical practitioners, pharmacists and intern pharmacists, nurse practitioners, endorsed midwives, dentists, podiatric surgeons and endorsed podiatrists) are required to check QScript before prescribing, dispensing or giving a treatment dose of a monitored medicine for a patient, and must comply with the minimum requirements stipulated in the Monitored Medicines Standard,2 if prescribing a monitored medicine for dispensing, or for giving a treatment dose, or if dispensing a monitored medicine for a patient. 

LEARNING OUTCOMES:

By the end of this module, learners will be able to identify appropriate clinical strategies when alerted by QScript to high-risk clinical scenario's: 

  • A – patient is currently registered on the Queensland Opioid Treatment Program (QOTP).
  • B - patient was previously registered on the Queensland Opioid Treatment Program (QOTP)
  • C - patient receiving monitored medicines from multiple prescribers
  • D - increased patient overdose risk— average total daily opioids of 100mg oral morphine equivalent (OME) or greater
  • E - increased patient overdose risk—opioid and benzodiazepine / z-drug (zopiclone and zolpidem) combination
  • F - patient receiving an opioid or benzodiazepine / z-drug for the first time in 90 days
LENGTH:2 hours
CPD:

This module is accredited for:

  • 1.5 hours of Educational Activities and 0.5 hours of Reviewing Performance with RACGP;
  • 2.0 hours of CPD with ACRRM; and
  • 2.25 hours of Group 1 CPD (or 2.25 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan which can be converted to 2.25 hr of Group 2 CPD (or 4.5 CPD credits) upon successful completion of relevant assessment activities with APC.

Please refer to your Statement of Completion for full details.

NB: Insight uploads CPD hours quarterly to ACRRM and RACGP. 

ACKNOWLEDGEMENTS:QScript Learning was funded by the Prevention Division within the Queensland State Government’s Department of Health.  
REFERENCE LIST:Available here
LAST UPDATED:February 2023